Weekly Update: Market Volatility Directs to Greater Volumes for NYSE Euronext Galaxy Stocks Abbott Laboratories Inc. (NYSE:ABT) on Saturday reported constructive data from a trial to assess an investigational compound called daclizumab high-yield process in people suffering from a certain kind of multiple sclerosis. ... |
